• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Ardent Health Appoints Dave Caspers as CEO

    6/2/26 4:15:00 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care
    Get the next $ARDT alert in real time by email

    Mr. Caspers brings decades of operational expertise and a deep understanding of Ardent Health's mission to enhance healthcare access and service

    Transition positions Ardent Health for its next phase of growth centered on operational efficiency and sharpening execution, building on the strong foundation established under Marty Bonick's leadership

    Reaffirms full-year 2026 Adjusted EBITDA guidance

    Ardent Health (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that Dave Caspers has been appointed President and Chief Executive Officer, effective immediately. Mr. Caspers, who previously served as Chief Operating Officer, succeeds Marty Bonick, who has stepped down to pursue other opportunities. In addition, Mr. Caspers has been appointed to the Company's Board of Directors.

    "On behalf of the Board, I am pleased to announce Dave's appointment as President and Chief Executive Officer," said Mark Sotir, Chairman of the Ardent Health Board of Directors. "Dave brings decades of operational experience and a strong understanding of Ardent Health's mission and strategy. We are confident in his ability to lead the Company forward as we sharpen our focus on operational excellence and long-term growth as part of our ongoing transformation."

    The appointment of Mr. Caspers reflects a leadership transition aligned with the Company's focus on executing its operating and growth strategies, enhancing the delivery of quality care, and driving sustained performance in a dynamic operating environment. This follows the Company's successful transformation and initial public offering under Mr. Bonick's leadership, which positioned the business for continued advancement of its mission to make healthcare better for the patient, the providers and team members, and the communities it serves.

    Since joining Ardent Health in March 2025, Mr. Caspers has led company-wide operational initiatives and advanced key growth priorities, including overseeing our IMPACT program, which was implemented to improve margins, performance, agility, and care transformation. Mr. Caspers has significant leadership experience in retail healthcare and health system operations, with a proven track record of driving growth, optimizing performance, and scaling complex organizations. Prior to Ardent Health, Mr. Caspers held senior leadership roles at Walmart Health, Banner Health, and Target. At Walmart Health, he oversaw large-scale healthcare systems and omnichannel care delivery, including responsibility for in-store clinics and virtual health services. At Banner Health, he directed the design, scaling, optimization, and remediation of operations across 30 hospitals, 350 clinics, and 60 urgent care facilities, and at Target Corporation, he led retail healthcare operations.

    Mr. Caspers said, "I am honored to step into the role of President and CEO at this important moment in Ardent Health's history. Over the past year, I have had the privilege of working closely with Marty, whose leadership and guidance have been instrumental in laying the solid footing on which Ardent Health now stands. Today, Ardent Health and our best-in-class team are well-positioned to accelerate our next phase of growth, and I am eager to build on this momentum with a continued focus on delivering high-quality care to the communities we serve."

    Commenting on the Company's financial outlook, Alfred Lumsdaine, Chief Financial Officer, said "During the second quarter, we've observed volume softness across our portfolio. We have taken appropriate and decisive action, including accelerating and expanding our IMPACT program. Based on these actions and the current environment, we are reaffirming our full-year 2026 Adjusted EBITDA guidance of $485 to $535 million."

    "I also want to express my sincere gratitude to Marty for his leadership during a pivotal period for Ardent Health," Mr. Sotir continued. "He played an instrumental role in guiding the organization through COVID-19, operational improvements, and our initial public offering, positioning the business for sustained long-term growth and helping build a strong foundation as the Company continues to navigate industry headwinds with a focus on disciplined execution. We wish him all the best in his next chapter."

    About Ardent Health

    Ardent Health is a leading provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in innovative services and technologies, Ardent Health is passionate about making healthcare better and easier to access. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 employed and affiliated providers across six states. For more information, please visit www.ardenthealth.com.

    Forward-Looking Statements

    This press release may contain "forward-looking statements," as that term is defined in the U.S. federal securities laws. These forward-looking statements include, but are not limited to, statements other than statements of historical facts, including, among others, statements relating to the expected benefits of the leadership transition, our future financial performance, our business prospects and strategy, the industry in which we operate and other similar matters. Words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "could," "would," "will," "may," "can," "continue," "potential," "should," and the negative of these terms or other comparable terminology often identify forward-looking statements. When reviewing this press release, you should keep in mind the risks and uncertainties that could impact our business. These forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results to differ materially from the results contemplated by the forward-looking statements. These risks and uncertainties could cause actual results to differ materially from those projected in forward-looking statements contained in this press release or implied by past results and trends. Our historical results are not necessarily indicative of the results that may be expected for any period in the future. Factors, risks, and uncertainties that could cause actual outcomes and results to be materially different from those contemplated include, among others: (1) the impact of the CEO transition on relationships with patients, vendors, regulators, employees, and investors and the ability of the new CEO to execute on the Company's current and future strategies and (2) risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2025 and in the Company's subsequent filings with the Securities and Exchange Commission. Many of the important factors that will determine these results are beyond our ability to control or predict. You are cautioned not to put undue reliance on any forward-looking statements, which speak only as of the date of this press release. The forward-looking statements in this press release are based on management's current beliefs, expectations, and projections about future events and trends affecting our business, results of operations, financial condition, and prospects. Except as otherwise required by law, we do not assume any obligation to publicly update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect the occurrence of unanticipated events. All references to "Company," "Ardent Health," "Ardent," "we," "our," and "us" as used throughout this release refer to Ardent Health, Inc. and its affiliates, unless stated otherwise or indicated by context.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260602097724/en/

    Investor:

    Dave Styblo, CFA

    Investor.Relations@ardenthealth.com

    (615) 296-3016



    Media:

    Rebecca Kirkham

    rebecca.kirkham@ardenthealth.com

    (615) 296-3000

    Get the next $ARDT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARDT

    DatePrice TargetRatingAnalyst
    11/17/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    11/14/2025Overweight → Equal-Weight
    Morgan Stanley
    10/14/2025$19.00Neutral
    Goldman
    9/10/2025$17.00Buy
    UBS
    7/16/2025$14.60Neutral → Underperform
    BofA Securities
    12/17/2024$20.00Neutral
    Analyst
    11/6/2024$22.00 → $19.00Buy → Neutral
    BofA Securities
    10/11/2024$24.00Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $ARDT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ardent Health downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Ardent Health from Overweight to Sector Weight

    11/17/25 9:39:33 AM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    Ardent Health downgraded by Morgan Stanley

    Morgan Stanley downgraded Ardent Health from Overweight to Equal-Weight

    11/14/25 9:48:25 AM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    Goldman initiated coverage on Ardent Health with a new price target

    Goldman initiated coverage of Ardent Health with a rating of Neutral and set a new price target of $19.00

    10/14/25 8:47:11 AM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    $ARDT
    SEC Filings

    View All

    Ardent Health Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Ardent Health, Inc. (0001756655) (Filer)

    6/2/26 4:23:36 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    Ardent Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Ardent Health, Inc. (0001756655) (Filer)

    5/26/26 4:37:35 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    SEC Form 10-Q filed by Ardent Health Inc.

    10-Q - Ardent Health, Inc. (0001756655) (Filer)

    5/6/26 4:19:42 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    $ARDT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Webb Robert Thomas bought $339,600 worth of shares (20,000 units at $16.98), increasing direct ownership by 99% to 40,275 units (SEC Form 4)

    4 - Ardent Health Partners, Inc. (0001756655) (Issuer)

    11/13/24 4:41:55 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    $ARDT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ardent Health to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that the Company will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Wednesday, June 10, 2026, in Miami, Florida. Members of the management team will participate in a fireside chat on June 10, 2026, at 11:20 a.m. ET. A live audio webcast of the event will be available in the Investor Relations section of the Company's website, at ir.ardenthealth.com. A replay will be accessible on the same page following the session. In conjunction with the conference, the Ardent Health management team will be available to participate in one-on

    6/3/26 4:15:00 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    Ardent Health Appoints Dave Caspers as CEO

    Mr. Caspers brings decades of operational expertise and a deep understanding of Ardent Health's mission to enhance healthcare access and service Transition positions Ardent Health for its next phase of growth centered on operational efficiency and sharpening execution, building on the strong foundation established under Marty Bonick's leadership Reaffirms full-year 2026 Adjusted EBITDA guidance Ardent Health (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that Dave Caspers has been appointed President and Chief Executive Officer, effective immediately. Mr. Caspers, who previously s

    6/2/26 4:15:00 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    Ardent Health and Fujifilm Partner to Deliver Synapse Enterprise Imaging Across Radiology and Cardiology Throughout All Facilities

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., has partnered with FUJIFILM Healthcare Americas Corporation to implement its Synapse® enterprise imaging solutions across Ardent's acute care hospital footprint across six states. Fujifilm's Synapse Enterprise Imaging solutions will provide Ardent clinicians with a single, holistic view of patient imaging data across various departments, including radiology and cardiology, through a unified Fujifilm Synapse Diagnostic PACS viewer. Having centralized access to all patient imaging in Synapse VNA improves workflow efficiency by streamlining operations across different departmen

    5/14/26 8:00:00 AM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    $ARDT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Bulgarelli Peter J.

    4 - Ardent Health, Inc. (0001756655) (Issuer)

    4/2/26 4:51:28 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    SEC Form 4 filed by Havdala Ellen

    4 - Ardent Health, Inc. (0001756655) (Issuer)

    4/2/26 4:51:07 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    SEC Form 4 filed by Sotir Mark R

    4 - Ardent Health, Inc. (0001756655) (Issuer)

    4/2/26 4:50:39 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    $ARDT
    Leadership Updates

    Live Leadership Updates

    View All

    Ardent Health Appoints Chief Development Officer to Lead Strategic Growth

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Chris Schoeplein as chief development officer. In this new role, Schoeplein will lead development efforts across Ardent's existing markets and support the organization's expansion into new regions. He will be responsible for driving growth across inpatient and outpatient care settings through acquisitions, partnerships and joint ventures. Additionally, he will guide due diligence, market intelligence and integration planning to advance Ardent's long-term growth strategy. "We are excited to welcome Chris to Ardent at a pivotal time in our gr

    5/19/25 4:30:00 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    Ardent Health Appoints Robert DeMichiei to Board of Directors

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U

    4/3/25 5:27:00 PM ET
    $AP
    $ARDT
    $HCAT
    Fluid Controls
    Industrials
    Hospital/Nursing Management
    Health Care

    Ardent Health Announces Appointment of Chief Operating Officer and Senior Leadership Promotions

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Dave Caspers as chief operating officer. In this new role, Caspers will oversee operations across Ardent Health, which includes 30 hospitals and 280 sites of care in six states. He will be responsible for executing on strategic growth initiatives and driving operational excellence at an enterprise level. Caspers will also lead efforts to further optimize and scale the company's consumer-centric operating model across new and existing markets. "We are pleased to welcome Dave to Ardent," said Ardent Health President and CEO Marty Bonick. "His

    3/31/25 4:30:00 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    $ARDT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Ardent Health Partners Inc.

    SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)

    11/14/24 6:07:29 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by Ardent Health Partners Inc.

    SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)

    11/14/24 4:45:09 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by Ardent Health Partners Inc.

    SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)

    11/14/24 4:27:52 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    $ARDT
    Financials

    Live finance-specific insights

    View All

    Ardent Health Reports First Quarter 2026 Results

    Ardent Health, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended March 31, 2026. First Quarter 2026 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.60 billion 7.0% growth Y/Y Net Income Attributable to Ardent Health $40 million Adjusted EBITDA(1) $124 million 26.3% growth Y/Y Adjusted EBITDAR(1) $16

    5/5/26 4:15:00 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    Ardent Health Announces First Quarter 2026 Results Conference Call and Webcast Date

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its first quarter 2026 results after the market closes on Tuesday, May 5, 2026. A conference call will be held the following day, Wednesday, May 6, 2026, at 10 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to register, do

    4/16/26 4:15:00 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care

    Ardent Health Announces Fourth Quarter and Full Year 2025 Results Conference Call and Webcast Date

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its fourth quarter and full year 2025 results after the market closes on Wednesday, March 4, 2026. A conference call will be held the following day, Thursday, March 5, 2026, at 10 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in o

    2/12/26 4:30:00 PM ET
    $ARDT
    Hospital/Nursing Management
    Health Care